Michael Richman

Insider Reports History

Location
Houston, TX
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Richman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NextCure, Inc. President & CEO, Director Employee Stock Option (Right to Buy) 306K 31 Jan 2025 Direct
NextCure, Inc. President & CEO, Director Employee Stock Option (Right to Buy) 244K 29 Mar 2024 Direct
PIERIS PHARMACEUTICALS, INC. Director Stock Option (right to buy) 40K 21 Jun 2023 Direct

Insider Reports Filed by Michael Richman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NXTC NextCure, Inc. 31 Jan 2025 1 $0 4 President & CEO, Director 03 Feb 2025, 18:22
NXTC NextCure, Inc. 29 Mar 2024 1 $0 4 President & CEO, Director 02 Apr 2024, 16:44
NXTC NextCure, Inc. 31 Jan 2024 1 $0 4 President & CEO, Director 01 Feb 2024, 16:45
PIRS PIERIS PHARMACEUTICALS, INC. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:45
NXTC NextCure, Inc. 28 Feb 2023 1 $0 4 President & CEO, Director 01 Mar 2023, 17:01
PIRS PIERIS PHARMACEUTICALS, INC. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 19:02
NXTC NextCure, Inc. 31 Jan 2022 1 $0 4 President & CEO, Director 02 Feb 2022, 15:18
PIRS PIERIS PHARMACEUTICALS, INC. 25 Jun 2021 1 $0 4 Director 29 Jun 2021, 17:33